Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
AVALON GLOBOCARE Aktie jetzt für 0€ handeln | |||||
Do | Avalon GloboCare, Qi To Co-develop VOC Nanosensor-based Cannabis Breathalyzer | 1 | RTTNews | ||
Do | Avalon GloboCare Corp.: Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving | 2 | GlobeNewswire (USA) | ||
Do | Avalon GloboCare Corp. - 8-K, Current Report | 2 | SEC Filings | ||
10.06. | Avalon GloboCare Corp. - S-4/A, Registration of securities, business combinations | - | SEC Filings | ||
04.06. | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings | ||
23.05. | Avalon GloboCare droht Delisting von der Nasdaq wegen Eigenkapitalmangel | 2 | Investing.com Deutsch | ||
23.05. | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings | ||
13.05. | Avalon GloboCare Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
29.04. | Avalon GloboCare Corp. - 8-K, Current Report | - | SEC Filings | ||
24.04. | Avalon GloboCare Corp. - S-4, Registration of securities, business combinations | 1 | SEC Filings | ||
10.04. | Avalon GloboCare sichert Patent für CAR-T, CAR-NK Technologie in China | 1 | Investing.com Deutsch | ||
10.04. | Avalon GloboCare secures patent for CAR-T, CAR-NK technology in China | 2 | Investing.com | ||
10.04. | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings | ||
01.04. | Avalon GloboCare Corp. - 8-K, Current Report | 1 | SEC Filings | ||
01.04. | Avalon GloboCare Corp.: Avalon GloboCare Partners with Pounds Transformation Clinics to Unveil the KetoAir BrAce 4 Impact Challenge Series | 1 | GlobeNewswire (USA) | ||
31.03. | Avalon GloboCare Corp. - 10-K, Annual Report | 4 | SEC Filings | ||
10.03. | Avalon GloboCare Corp. - 8-K, Current Report | 2 | SEC Filings | ||
27.02. | Avalon GloboCare Corp. - 8-K, Current Report | 2 | SEC Filings | ||
18.02. | Avalon GloboCare secures patent in China for CAR therapy tech | 2 | Investing.com | ||
18.02. | Avalon GloboCare sichert sich Patent in China für CAR-Therapie-Technologie | 4 | Investing.com Deutsch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 90,70 | +0,06 % | Die nächste Cashcow? Schnelle Prozente mit NetraMark, Moderna, BioNTech | Erinnern Sie sich noch an den Impfstoff-Wettlauf in der Corona-Zeit? Damals bestimmte das Duell zwischen BioNTech und Curevac auch das Geschehen an der Börse. Anleger der ersten Stunde machten schnell... ► Artikel lesen | |
EVOTEC | 7,138 | -0,81 % | Evotec Aktie mit Verkaufssignal: Konter oder Sturz auf 5 Euro? | Die Evotec Aktie hat am Donnerstag ein charttechnisches Verkaufssignal ausgelöst. Mit einem XETRA-Schlusskurs von 6,568 Euro fiel der Kurs um mehr als vier Prozent und unterschritt dabei mehrere relevante... ► Artikel lesen | |
CUREVAC | 4,560 | -1,00 % | EQS-News: CureVac Announces Voting Results of General Meeting | Emittent / Herausgeber: CureVac
/ Schlagwort(e): Hauptversammlung
CureVac Announces Voting Results of General Meeting
24.06.2025 / 22:09 CET/CEST
Für den Inhalt der... ► Artikel lesen | |
AMGEN | 237,00 | -0,63 % | ROUNDUP/Aktien New York Schluss: Gewinne - 'Iran-Angriff eine Gesichtswahrung' | NEW YORK (dpa-AFX) - Der Nahost-Krieg hat am Montag die Richtung an den US-Börsen bestimmt. Die wichtigsten US-Indizes legten am Ende kräftig zu und erreichten kurz vor dem Handelsschluss Tageshöchststände.... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,470 | -0,63 % | Defence Therapeutics Inc.: Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology | Montreal, Quebec--(Newsfile Corp. - June 9, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug... ► Artikel lesen | |
IDEXX LABORATORIES | 448,60 | -0,55 % | What Makes IDEXX Laboratories (IDXX) a Good Investment? | ||
NUREXONE BIOLOGIC | 0,450 | +1,35 % | Breaking News: Prestigeträchtige Auszeichnung für NurExone! | ||
IBIO | 0,745 | +6,03 % | Pharos iBio Receives IND Approval for PHI-501 Phase 1 Trial | ||
ARROWHEAD PHARMACEUTICALS | 13,400 | -2,37 % | Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results | PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting... ► Artikel lesen | |
COHERUS ONCOLOGY | 0,643 | +2,68 % | Coherus Oncology, Inc.: Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics | REDWOOD CITY, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Coherus Oncology, Nasdaq: CHRS), a commercial-stage innovative oncology company, formerly named Coherus BioSciences Inc.... ► Artikel lesen | |
BIOXCEL THERAPEUTICS | 1,360 | -100,00 % | BioXcel stock price target raised to $8 from $3 at H.C. Wainwright | ||
ADAPTIMMUNE THERAPEUTICS | 0,206 | 0,00 % | Mizuho downgrades Adaptimmune stock on solvency concerns | ||
VOYAGER THERAPEUTICS | 2,494 | -1,89 % | Voyager Therapeutics, Inc.: Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication | LEXINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced... ► Artikel lesen | |
ANAVEX LIFE SCIENCES | 8,300 | +4,48 % | Anavex Life Sciences Corp. Q2 Loss Beats Estimates | WASHINGTON (dpa-AFX) - Anavex Life Sciences Corp. (AVXL) released Loss for second quarter that beat the Street estimates.The company's earnings came in at -$11.20 million, or -$0.13 per share.... ► Artikel lesen | |
OPGEN | 2,600 | 0,00 % | OPGEN INC - 8-K, Current Report |